3Department of Health and Human Services, Centers for Disease Control and Prevention, U S A. Clinical Laboratory Improvements Amendments of 1988 (CLIA'88) : final rules. 1992-02-28.
4ISO 17025 : 1999. General requirements for competence of calibration and testing laboratories .
5ISO 15189 : 2003 (E). Medical laboratories : particular requirements for quality and competence.
6Hamlin WB. Requirements for accreditation by the College of American Pathologists Laboratory Accreditation Program. Arch Pathol Lab Med, 1999,123:465-467.
7Sabattini E,Bisgaard K,Ascani S,et al.The EnVision++system:a new immunohistochemical method for diagnostics and research critical comparison with the APAAP,ChemMate,CSA,LABC and SABC techniques[J].J Clin Pathol,1998,51(7):506-511.
6Werling RW, Hwang H, Yaziji H, et al. Immunohistochemical distinction of invasive from noninvasive breast lesions. Am J Surg Pathol,2003,27: 82-90.
7Barbareschi M, Pacciarini L, Cangi MG, et al. p63, a p53 homologue is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Patho1,2001,25 : 1054-1060.
